Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis.
A cross-sectional study examining multiple mobility device use and fall status among middle-aged and older adults with multiple sclerosis.
Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial.
Remote effects of intermittent theta burst stimulation of the human pharyngeal motor system.
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis.
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
Is multiple sclerosis a proresolution deficiency disorder?
Pregnancy outcomes in multiple sclerosis patients previously treated with cyclophosphamide.
Correlates of Executive Functions in Multiple Sclerosis Based on Structural and Functional MR Imaging: Insights from a Multicenter Study.
Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor γ
Pain Research Forum: application of scientific social media frameworks in neuroscience.
The prospects of minocycline in multiple sclerosis.
Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Causes of Death among Commercially Insured Multiple Sclerosis Patients in the United States.
Tremor reduction and quality of life after deep brain stimulation for multiple sclerosis-associated tremor.
Central nervous system lymphoma associated with natalizumab.
Including known covariates can reduce power to detect genetic effects in case-control studies.
New technologies for biomarker discovery in multiple sclerosis.
New Disease-Modifying Therapies and New Challenges for MS.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
Efficacy of fingolimod in patients with highly active relapsing-remitting multiple sclerosis.
Acute reversible periependymal ventricular enhancement in neuromyelitis optica.

Pages